US Patent Issued to Roche Diabetes Care on Sept. 8 for "Method and system for generating a software-implemented module for determining an analyte value, computer program product, and method and system for determining an analyte value" (German, Swiss Inventors)

Posted On: 2026-09-08

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,731,684, issued on Sept. 8, was assigned to Roche Diabetes Care Inc. (Indianapolis).

"Method and system for generating a software-implemented module for determining an analyte value, computer program product, and method and system for determining an analyte value" was invented by Larissa Becka (Munich), Alexander Buesser (Zurich, Switzerland), Tony Huschto (Speyer, Germany), Yannick Klopfenstein (Neuchatel, Switzerland), David Mesterhazy (Nuremberg, Germany), Mike Rinderknecht (Zurich, Switzerland) and Christian Ringemann (Mannheim, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method for generating a software-implemented module for determini...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

US Patent Issued to Roche Diabetes Care on Sept. 8 for "Method and system for generating a software-implemented module for determining an analyte value, computer program product, and method and system for determining an analyte value" (German, Swiss Inventors)